NDC 72606-051-06 - Tocilizumab-anoh
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 72606-051
- Requested NDC
- 72606-051-06
- Package NDCs from labels
- 72606-051-01, 72606-051-02, 72606-051-03, 72606-051-04, 72606-051-05, 72606-051-06
- Manufacturer
- CELLTRION USA, Inc.
- Effective date
- 2026-01-23
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Tocilizumab-anoh - CELLTRION USA, Inc. | CELLTRION USA, Inc. | 2026-01-23 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 72606-051-01 | Tocilizumab-anoh | 0.9 mL in 1 SYRINGE, GLASS | INJECTION, SOLUTION, CONCENTRATE | 0.9 | 4 | |
| 72606-051-01 | Tocilizumab-anoh | 1 in 1 CARTON | INJECTION, SOLUTION, CONCENTRATE | 1 | 4 | |
| 72606-051-02 | Tocilizumab-anoh | 0.9 mL in 1 SYRINGE, GLASS | INJECTION, SOLUTION, CONCENTRATE | 0.9 | 4 | |
| 72606-051-02 | Tocilizumab-anoh | 4 in 1 CARTON | INJECTION, SOLUTION, CONCENTRATE | 4 | 4 | |
| 72606-051-03 | Tocilizumab-anoh | 12 in 1 CARTON | INJECTION, SOLUTION, CONCENTRATE | 12 | 4 | |
| 72606-051-03 | Tocilizumab-anoh | 0.9 mL in 1 SYRINGE, GLASS | INJECTION, SOLUTION, CONCENTRATE | 0.9 | 4 | |
| 72606-051-04 | Tocilizumab-anoh | 0.9 mL in 1 SYRINGE, GLASS | INJECTION, SOLUTION, CONCENTRATE | 0.9 | 4 | |
| 72606-051-04 | Tocilizumab-anoh | 1 in 1 CARTON | INJECTION, SOLUTION, CONCENTRATE | 1 | 4 | |
| 72606-051-05 | Tocilizumab-anoh | 4 in 1 CARTON | INJECTION, SOLUTION, CONCENTRATE | 4 | 4 | |
| 72606-051-05 | Tocilizumab-anoh | 0.9 mL in 1 SYRINGE, GLASS | INJECTION, SOLUTION, CONCENTRATE | 0.9 | 4 | |
| 72606-051-06 | Tocilizumab-anoh | 12 in 1 CARTON | INJECTION, SOLUTION, CONCENTRATE | 12 | 4 | |
| 72606-051-06 | Tocilizumab-anoh | 0.9 mL in 1 SYRINGE, GLASS | INJECTION, SOLUTION, CONCENTRATE | 0.9 | 4 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| TYENNE | TOCILIZUMAB-AAZG | Fresenius Kabi USA, LLC | ad76441d-da59-47df-8d9d-2243005180f0 | 2026-08-26 | Boxed warning, Warnings, Adverse reactions | I031V2H011 |
| AVTOZMA | TOCILIZUMAB | CELLTRION USA, Inc. | 581c288f-8015-40ef-a4c3-683c96db193d | 2026-07-27 | Boxed warning, Warnings, Adverse reactions | 2705425 2705443 2705450 2705435 2705452 I031V2H011 |
| TYENNE | TOCILIZUMAB-AAZG | Fresenius Kabi USA, LLC | 87ac5047-4f2b-4571-a8a8-32e08865f379 | 2026-07-23 | Boxed warning, Warnings, Adverse reactions | I031V2H011 |
| TOFIDENCE | TOCILIZUMAB | Organon LLC | 1ab3207a-ebfe-4565-9ce5-3a1538815c83 | 2026-05-22 | Boxed warning, Warnings, Adverse reactions | I031V2H011 |
| TYENNE | TOCILIZUMAB-AAZG | Fresenius Kabi USA, LLC | e400bbe6-43c5-4de6-82b9-cb44ce3cd906 | 2026-05-15 | Boxed warning, Warnings, Adverse reactions | I031V2H011 |
| bacf86b8-9d2f-45d2-9c35-4f619ea494aa | 60381a7e-d7ae-4384-925d-c19c418d1663 | 2026-01-23 | Boxed warning, Warnings, Adverse reactions | bacf86b8-9d2f-45d2-9c35-4f619ea494aa 60381a7e-d7ae-4384-925d-c19c418d1663 | ||
| Tofidence | TOCILIZUMAB | Biogen MA Inc | 00529b23-850a-42b9-a152-125a95b5242c | 2025-12-19 | Boxed warning, Warnings, Adverse reactions | I031V2H011 |
| ACTEMRA | TOCILIZUMAB | Genentech, Inc. | 2e5365ff-cb2a-4b16-b2c7-e35c6bf2de13 | 2025-12-16 | Boxed warning, Warnings, Adverse reactions | I031V2H011 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.